Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Open label, Antibody-drug conjugate, Conjugate, and Randomized controlled trial.
Injectable anticancer biodegradable hydrogel-based nanocomposites: Synergistic pH-responsive paclitaxel/β-cyclodextrin nanocomplex delivery in polyvinyl alcohol hydrogel for targeted pancreatic ductal adenocarcinoma treatment
A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) in gastric or gastroesophageal junction adenocarcinoma (G/GEJA): Trial in progress.
A Novel Dietary Index for Gut Microbiota ( <scp>DI</scp> ‐ <scp>GM</scp> ) is Associated With Inflammation, Mental Health, and Tumor Biomarkers in Adults: A Cross‐Sectional Study
Case report: Kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor
Tumor-Associated Macrophage-Derived Exosomes Promote the Progression of Gastric Cancer by Regulating the P38MAPK Signaling Pathway and the Immune Checkpoint PD-L1
Efficacy and safety of sintilimab-based regimens against advanced gastric and gastroesophageal junction adenocarcinoma
LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma